When a ‘Miracle’ Drug Is Out of Reach

Trikafta’s U.S. list price is over $322,000 a year. That is nearly 60 times the annual salary of a minimum wage earner in Turkey, where the government wanted to import a generic version made in Argentina. Vertex sued and blocked it.

Vertex has brought in $17 billion from Trikafta since 2019. An analysis by researchers in Britain found that a year’s supply of the drug could be manufactured for just $5,700.

The company says it is working to increase access to the drug globally.



About Author

You may also like


Women Have Been Misled About Menopause

Hot flashes, sleeplessness, pain during sex: For some of menopause’s worst symptoms, there’s an established treatment. Why aren’t more women

What to Know About Menopause and Hormone Therapy

There has long been an effective, F.D.A.-approved treatment for some menopausal symptoms, but too few women have a clear picture